D-3-Phosphoglycerate dehydrogenase from M. tuberculosis displays substantial substrate inhibition by its physiological substrate in the direction of NADH oxidation, hydroxypyruvic acid phosphate (HPAP). Previous investigations showed that plots of substrate concentration versus activity derived from steady state assays could be fit with the equation for complete uncompetitive inhibition and that the mechanism may be allosteric. This investigation uses a simulation of transient kinetic data to demonstrate that the mechanism is consistent with the interaction of substrate at a second site called the anion-binding site. While substrate addition at the active site is ordered, with HPAP binding before NADH, NADH can compete with the substrate for binding to the allosteric site and thereby eliminate the substrate inhibition. Fluorescence resonance energy transfer analysis of mutants with specific tryptophan residues converted to phenylalanine residues demonstrates that the main interaction of NADH with the enzyme, in the absence of substrate, is at the allosteric anion-binding site. This is further confirmed by mutations of basic residues at the anion-binding site which also demonstrates that these residues are necessary for inhibition by L-serine when it binds to the regulatory domain. This may indicate that a ligand must be bound to the anion-binding site for Lserine inhibition, providing a potential mechanism for low levels of activity in the presence of high levels of inhibitor.D-3-phosphoglycerate dehydrogenase (PGDH 1 ) ( EC 1.1.1.95) from Mycobacterium tuberculosis (M. tb) is a homotetramer whose subunit's are identical in their primary structure but not in their tertiary structure. The crystal structure of M. tb PGDH (1) shows that the subunits are present in two different conformations that arise from a rotation about an interdomain connecting strand. Each subunit is made up of four distinct globular domains termed the nucleotide binding domain, the substrate binding domain, the intervening domain, and the regulatory domain. Residues 1-99 and 283-319 form the substrate binding domain, and residues 100-282 form the nucleotide binding domain. The intervening domain is made up of residues 320-454 and residues 455-529 complete the regulatory domain. The conformational rotation takes place in the strand that connects the substrate binding domain to the intervening domain. *Corresponding Author: Gregory A. Grant, Department of Medicine and of Developmental Biology, Washington University School of Medicine, St. Louis, As with E. coli PGDH (2), M. tb PGDH is inhibited by L-serine (3), which binds at the interface between adjacent regulatory domains in both enzymes. The regulatory domains are members of the ACT domain family (4) that are found in a large number of bacterial proteins mostly involved in amino acid metabolism or transcriptional regulation of amino acid biosynthesis.The intervening domain represents an additional domain not found in E. coli PGDH that "intervenes" between the substrate binding and ...